| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8234362 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 5 Pages |
Abstract
These data suggest that an optimal window exists for combining bevacizumab with radiotherapy that determines whether the combination will be beneficial and that the imaging of HIF-1 activity would be useful in determining this window.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Guangfei M.D., Ph.D., Satoshi M.D., Lihua Ph.D., Keiko M.D., Ph.D., Junlin M.D., Ph.D., Hiroshi Ph.D., Masahiro M.D., Ph.D.,